Skip to search formSkip to main contentSkip to account menu

CK 3197

Known as: 2H-Imidazol-2-one, 1-benzoyl-5-(4-(4,5-dihydro-2-methyl-1H-imidazol-1-yl)benzoyl)-4-ethyl-1,3-dihydro-, CK-3197 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Imidazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Hemodynamic and Myocardial Energetic Effects of CK‐3197, a Selective Positive Inotropic Agent
CK-3197 was developed as a selective positive inotropic agent for the treatment of congestive heart failure. We compared the… 
1991
1991
Ouabain pretreatment does not compromise the hemodynamic and myocardial energetic effects of CK‐3197, a selective positive inotropic agent, in dogs with propranolol‐induced heart failure
We examined the interaction between ouabain and CK‐3197, a new selective positive inotrope, on the hemodynamic and myocardial… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)